← brief for 2026-10-16 · Slowing decline
SGLT2 inhibitors and cardiovascular outcomes in patients with moderate-to-severe psoriasis receiving biologic therapy: A propensity score-matched cohort study.
Key takeaways
This study looked at 2,016 people with severe skin disease who were taking a diabetes drug. It found a link between the drug and lower heart risks. This is an observational study, so it shows a connection but not proof of cause. The drug is known to help kidneys and hearts in other groups.
Who did this work
Gotor-Rivera A · Hernández Sánchez J · Chamorro Jiménez E · García Rivera E · Ortiz Romero PL · Rivera-Diaz R
Source
Article · PubMed, the drug frontier · 2026 Oct 16
https://pubmed.ncbi.nlm.nih.gov/42887863/